highly significantP < 0.001
Following baicalein pretreatment, cell migration was markedly inhibited: the wound closure rate in the high-dose group decreased to 6.3%, showing a highly significant difference compared to the Model group (P < 0.001).
Following baicalein pretreatment, cell migration was markedly inhibited: the wound closure rate in the high-dose group decreased to 6.3%, showing a highly significant difference compared to the Model group (P < 0.001).
In contrast, the Low-dose group exhibited a marginal reduction to 2.91 ± 0.11 mm at t7, which did not reach statistical significance compared to the Model group ( P > 0.05 ) ( Table 2 ).
The medium and low-dose groups also showed a trend of improvement, though the effects were less pronounced than in the high-dose group.